Pulmonary Hypertension (PH) Completed Phase 4 Trials for Ranolazine (DB00243)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02829034Targeting Right Ventricle in Pulmonary Hypertension GileadTreatment
NCT01839110Targeting the Right Ventricle in Pulmonary HypertensionTreatment
NCT02133352Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular DysfunctionTreatment